Ligand validation:2H10

TBE: TAZOBACTAM INTERMEDIATE

TBE is a Ligand Of Interest in 2H10 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2H10_TBE_A_501	19%	7%	0.213	0.809	3.06	1.76	3	2	1	0	100%	1
1TDG_TBE_A_701	43%	0%	0.157	0.878	14.36	20.53	7	4	1	0	100%	0.33
3NIA_TBE_A_288	86%	17%	0.088	0.957	2.84	0.84	3	-	0	0	100%	0.9715
6XFS_TBE_A_501	54%	40%	0.139	0.902	1.46	0.88	3	-	0	0	100%	1
4A5R_TBE_A_1292	50%	13%	0.167	0.916	2.87	1.13	3	1	0	0	100%	1
6H2I_TBE_B_501	40%	9%	0.191	0.904	2.79	1.67	4	2	0	0	100%	1
3ZNT_TBE_A_300	39%	16%	0.194	0.903	2.68	1.03	3	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.